As of 4:00pm ET
| +0.06 / +0.42%|
The 3 analysts offering 12-month price forecasts for Spero Therapeutics Inc have a median target of 26.00, with a high estimate of 30.00 and a low estimate of 16.00. The median estimate represents a +81.95% increase from the last price of 14.29.
The current consensus among 4 polled investment analysts is to Buy stock in Spero Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.